Scientific publisher Nature Publishing Group (NPG), UK, and BioCentury Publications, Inc., US, have announced a joint publishing agreement that will seek to leverage the business intelligence of BioCentury and the scientific expertise of NPG. Under the deal, the two companies will create new products and services that will look to improve the efficiency and speed with which innovative life science research is translated into commercial value by the biotechnology and pharmaceutical industries.
The biopharmaceutical industry and its investors are inundated with complex scientific papers describing the latest discoveries each week. According to MEDLINE, the US National Library of Medicine's bibliographic database of references to articles in life sciences, over 600,000 articles were added to the database in 2006 alone. This makes for an average of almost 12,000 new articles every week.
The BioCentury and NPG enterprise will help distill the flood of complex scientific papers by filtering and analysing key findings within the most up to-date scientific and business context. It will provide vital resources for biotechnology and pharmaceutical executives, business development specialists, drug discovery and development teams, venture capitalists and other investment professionals who wish to identify new projects and potential new partners. It will then find enabling technology and scan their environment for disruptive competitive advances.
More News in this Theme
